An international scientific team has successfully created a three-dimensional model of a cancerous tumour using a 3D printer. Their model could ultimately help discover new drugs and cast new light on how tumours develop, ...
May 27, 2015
0
7
Lots of potentially useful medical information is getting lost. McGill researchers discovered this when they looked into the lack of reporting of information from "stalled drug" trials in cancer, cardiovascular and neurological ...
Mar 9, 2015
0
8
In the ongoing struggle to prevent and manage seasonal flu outbreaks, animal models of influenza infection are essential to gaining better understanding of innate immune response and screening for new drugs. A research team ...
Oct 1, 2014
0
0
(HealthDay)—Coupled with worldwide marches demanding action on climate change, a new study warns that rising temperatures and altered weather patterns in the United States may soon exacerbate many existing health risks.
Sep 23, 2014
0
0
Yale School of Medicine researchers have discovered a protein that is the missing link in the complicated chain of events that lead to Alzheimer's disease, they report in the Sept. 4 issue of the journal Neuron. Researchers ...
Sep 4, 2013
0
1
Children with a particularly lethal cancer could benefit from potentially life-saving treatment, following breakthrough work led by researchers at the University of New South Wales (UNSW).
Aug 15, 2013
0
0
An existing FDA-approved drug improves cognitive function in a mouse model of Down syndrome, according to a new study by researchers at the Stanford University School of Medicine.
Jul 2, 2013
0
0
A simple lab-based skin test which eliminates the risk of adverse reactions to new drugs, cosmetics and household chemicals has been developed by a Newcastle University, UK team.
May 27, 2013
0
0
New engineered spider protein could be the start of a new generation of anti-venom vaccines, potentially saving thousands of lives worldwide. The new protein, created from parts of a toxin from the reaper spider, is described ...
May 9, 2013
0
0
A new class of investigational medicines may help to treat patients with cancers driven by mutations in genes such as BRAF or KRAS/NRAS, including those patients who have become resistant to therapies that target BRAF directly, ...
Apr 8, 2013
0
0
